Development and validation of combined symptom-medication scores for allergic rhinitis.

Asthma / drug therapy Humans Quality of Life Reproducibility of Results Rhinitis Rhinitis, Allergic / diagnosis
medication score quality-of-life rhinitis symptom score work

Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
07 2022
Historique:
revised: 22 11 2021
received: 22 10 2021
accepted: 04 12 2021
pubmed: 22 12 2021
medline: 2 7 2022
entrez: 21 12 2021
Statut: ppublish

Résumé

Validated combined symptom-medication scores (CSMSs) are needed to investigate the effects of allergic rhinitis treatments. This study aimed to use real-life data from the MASK-air We used MASK-air We assessed 317,176 days of MASK-air The mixed CSMS and the cluster-based CSMSs presented medium-high validity, reliability and accuracy, rendering them as candidates for primary endpoints in future rhinitis trials.

Sections du résumé

BACKGROUND
Validated combined symptom-medication scores (CSMSs) are needed to investigate the effects of allergic rhinitis treatments. This study aimed to use real-life data from the MASK-air
METHODS
We used MASK-air
RESULTS
We assessed 317,176 days of MASK-air
CONCLUSION
The mixed CSMS and the cluster-based CSMSs presented medium-high validity, reliability and accuracy, rendering them as candidates for primary endpoints in future rhinitis trials.

Identifiants

DOI: 10.1111/all.15199 PMID: 34932829
pubmed: 34932829
doi: 10.1111/all.15199
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2147-2162

Informations de copyright

© 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

Godicke V, Hundt F. Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline. Allergy. 2010;65(12):1499-1505.
Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019;74(11):2087-2102.
Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854-867.
Pfaar O, Agache I, Blay F, et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy. 2019;74(Suppl 108):3-25.
Bousquet JJ, Schünemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9:44.
Bousquet J, Anto JM, Haahtela T, et al. Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland's Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing. Clin Transl Allergy. 2020;10:24.
Bousquet J, Anto JM, Bachert C, et al. ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice. Allergy. 2021;76(1):168-190.
Bedard A, Anto JM, Fonseca JA, et al. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air((R)) App. Allergy. 2020;75(7):1672-1688.
Poole CD, Bannister CA, Andreasen JN, Andersen JS, Currie CJ. Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health Qual Life Outcomes. 2014;12:99.
Remenschneider AK, Scangas G, Meier JC, et al. EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis. Laryngoscope. 2015;125(5):1056-1061.
Di Fraia M, Tripodi S, Arasi S, et al. Adherence to prescribed E-Diary recording by patients with seasonal allergic rhinitis: observational study. J Med Internet Res. 2020;22(3):e16642.
Tripodi S, Giannone A, Sfika I, et al. Digital technologies for an improved management of respiratory allergic diseases: 10 years of clinical studies using an online platform for patients and physicians. Ital J Pediatr. 2020;46(1):105.
Bastl K, Bastl M, Bergmann KC, Berger M, Berger U. Translating the burden of pollen allergy into numbers using electronically generated symptom data from the patient's Hayfever diary in Austria and Germany: 10-year Observational Study. J Med Internet Res. 2020;22(2):e16767.
Mokkink LB, Boers M, van der Vleuten CPM, et al. COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study. BMC Med Res Methodol. 2020;20(1):293.
Bousquet J, Bewick M, Arnavielhe S, et al. Work productivity in rhinitis using cell phones: the MASK pilot study. Allergy. 2017;72(10):1475-1484.
Bousquet J, VandenPlas O, Bewick M, et al. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: the MASK Study. J Investig Allergol Clin Immunol. 2018;28(1):42-44.
Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy. 2018;73(9):1763-1774.
Sousa-Pinto B, Eklund P, Pfaar O, et al. Validity, reliability and responsiveness of daily monitoring visual analogue scales in MASK-air®. Clin Transl Allergy. 2021;11(7):e12062.
Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127-137.
Janssen MF, Birnie E, Haagsma JA, Bonsel GJ. Comparing the standard EQ-5D three-level system with a five-level version. Value Health. 2008;11(2):275-284.
Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010;65(8):1042-1048.
Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time. Clin Transl Allergy. 2012;2(1):16.
van der Leeuw S, van der Molen T, Dekhuijzen PNR, et al. The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts. NPJ Prim Care Respir Med. 2015;25:14107.
Harbiyeli DO, Gemicioglu B, Vehid HE, Bousquet J, Fonseca JA. Turkish language validity and reliability of the Control of Allergic Rhinitis and Asthma Test and its comparison with other scales. Clin Respir J. 2021;15(11):1210-1218.
Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics. 2004;22(4):225-244.
Bousquet J, Neukirch F, Bousquet P, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117(1):158-162.
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1983;4(5):353-365.
Bedard A, Basagana X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J Allergy Clin Immunol. 2019;144(1):135-143.e136.
Bedard A, Basagana X, Anto JM, et al. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK Study. Clin Transl Allergy. 2020;10(1):62.
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155-163.
Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000;53(5):459-468.
Caimmi D, Neukirch C, Louis R, Malard O, Thabut G, Demoly P. Effect of the use of intranasal spray of essential oils in patients with perennial allergic rhinitis: a prospective study. Int Arch Allergy Immunol. 2021;182:182-189.
Meltzer EO, Schatz M, Nathan R, Garris C, Stanford RH, Kosinski M. Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis. J Allergy Clin Immunol. 2013;131(2):379-386.
Justicia JL, Cardona V, Guardia P, et al. Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: the ESPIA questionnaire. J Allergy Clin Immunol. 2013;131(6):1539-1546.

Auteurs

Bernardo Sousa-Pinto (B)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
ORCID: 0000-0002-1277-3401

Luís Filipe Azevedo (LF)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
ORCID: 0000-0002-8421-2937

Marek Jutel (M)

Department of Clinical Immunology, Wrocław Medical University, Wroclaw, Poland.
ALL-MED Medical Research Institute, Wroclaw, Poland.

Ioana Agache (I)

Faculty of Medicine, Transylvania University, Brasov, Romania.
ORCID: 0000-0001-7994-364X

G Walter Canonica (GW)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Personalized Medicine, Asthma & Allergy -Humanitas Clinical & Research Centre, IRCCS, Rozzano, Italy.

Wienczyslawa Czarlewski (W)

Medical Consulting Czarlewski, Levallois, France.
ARIA, Montpellier, France.

Nikolaos G Papadopoulos (NG)

Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
ORCID: 0000-0002-4448-3468

Karl-Christian Bergmann (KC)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Philippe Devillier (P)

UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
ORCID: 0000-0001-6054-1886

Daniel Laune (D)

KYomed INNOV, Montpellier, France.

Ludger Klimek (L)

Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.
Center for Rhinology and Allergology, Wiesbaden, Germany.
ORCID: 0000-0002-2455-0192

Aram Anto (A)

ARIA, Montpellier, France.

Josep M Anto (JM)

ISGlobAL, Barcelona Institute for Global Health, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Patrik Eklund (P)

Computing Science Department, Umeå University, Umeå, Finland.

Rute Almeida (R)

MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal.

Anna Bedbrook (A)

MACVIA-France, Montpellier, France.

Sinthia Bosnic-Anticevich (S)

Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Local Health District, Sydney, New South Wales, Australia.

Helen A Brough (HA)

Division of Allergy/Immunology, University of South Florida, Tampa, Florida, USA.
ORCID: 0000-0001-7203-0813

Luisa Brussino (L)

Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Torino, Italy.

Victoria Cardona (V)

Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron & ARADyAL Research Network, Barcelona, Spain.
ORCID: 0000-0003-2197-9767

Thomas Casale (T)

Division of Allergy/Immunology, University of South Florida, Tampa, Florida, USA.

Lorenzo Cecchi (L)

SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
ORCID: 0000-0002-0658-2449

Denis Charpin (D)

Clinique des Bronches, Allergie et Sommeil, Hôpital Nord, Marseille, France.

Tomás Chivato (T)

School of Medicine, University CEU San Pablo, Madrid, Spain.

Elisio M Costa (EM)

Faculty of Pharmacy and Competence Center on Active and Healthy Ageing, University of Porto (Porto4Ageing), UCIBIO, REQUINTE, Porto, Portugal.

Alvaro A Cruz (AA)

Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Brazil.
ORCID: 0000-0002-7403-3871

Stephanie Dramburg (S)

Department of Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité Medical University, Berlin, Germany.

Stephen R Durham (SR)

Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London, London, UK.
ORCID: 0000-0001-5264-6207

Giulia De Feo (G)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

Roy Gerth van Wijk (R)

Section of Allergology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
ORCID: 0000-0002-9608-8742

Wystke J Fokkens (WJ)

Department of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.

Bilun Gemicioglu (B)

Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Tari Haahtela (T)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
ORCID: 0000-0003-4757-2156

Maddalena Illario (M)

Department of Public Health and Research and Development Unit, Federico II University and Hospital, Naples, Italy.

Juan Carlos Ivancevich (JC)

Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.

Violeta Kvedariene (V)

Department of Pathology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.
Faculty of Medicine, Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Vilnius University, Vilnius, Lithuania.

Piotr Kuna (P)

Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Poland.

Désirée E Larenas-Linnemann (DE)

Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
ORCID: 0000-0002-5713-5331

Michael Makris (M)

Allergy Unit "D Kalogeromitros", 2nd Department of Dermatology and Venereology, National & Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Greece.

Eve Mathieu-Dupas (E)

KYomed INNOV, Montpellier, France.

Erik Melén (E)

Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Mario Morais-Almeida (M)

Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
ORCID: 0000-0003-1837-2980

Ralph Mösges (R)

CRI-Clinical Research International-Ltd, Hamburg, Germany.

Joaquim Mullol (J)

Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Barcelona, Spain.
Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.

Kari C Nadeau (KC)

Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, California, USA.
ORCID: 0000-0002-2146-2955

Nhân Pham-Thi (N)

IRBA (Institut de Recherche bio-Médicale des Armées), Ecole Polytechnique Palaiseau, Bretigny, France.

Robyn O'Hehir (R)

Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University and Alfred Health, Melbourne, Victoria, Australia.

Frederico S Regateiro (FS)

Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Institute of Immunology, Faculty of Medicine, University of Coimbra, Portugal.
ICBR - Coimbra Institute for Clinical and Biomedical Research, CIBB, Coimbra, Portugal.

Sietze Reitsma (S)

Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands.

Boleslaw Samolinski (B)

Department of Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Warsaw, Poland.

Aziz Sheikh (A)

Usher Institute, The University of Edinburgh, Edinburgh, UK.

Cristiana Stellato (C)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
ORCID: 0000-0002-1294-8355

Ana Todo-Bom (A)

Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Peter Valentin Tomazic (PV)

Department of General ORL, H&NS, Medical University of Graz, ENT-University Hospital Graz, Austria.
ORCID: 0000-0001-6445-4800

Sanna Toppila-Salmi (S)

Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Antonio Valero (A)

Pneumology and Allergy Department CIBERES and Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Spain.

Arunas Valiulis (A)

Faculty of Medicine, Institute of Clinical Medicine & Institute of Health Sciences, Vilnius University, Vilnius, Lithuania.
European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.

Maria Teresa Ventura (MT)

Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.

Dana Wallace (D)

Nova Southeastern University, Fort Lauderdale, Florida, USA.

Susan Waserman (S)

Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.

Arzu Yorgancioglu (A)

Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.

Govert De Vries (G)

Peercode BV, Geldermalsen, The Netherlands.

Michiel van Eerd (M)

Peercode BV, Geldermalsen, The Netherlands.

Petra Zieglmayer (P)

Vienna Challenge Chamber, Vienna, Austria.
Competence Center for Allergology and Immunology, Karl Landsteiner University, Krems, Austria.

Torsten Zuberbier (T)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
ORCID: 0000-0002-1466-8875

Oliver Pfaar (O)

Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
ORCID: 0000-0003-4374-9639

João Almeida Fonseca (J)

Departamento Medicina da Comunidade, Informaçao e Decisao em Saude (MEDCIDS), Faculdada de Medicina da Universidade do Porto, Porto, Portugal.
Medicina, EDucaçao, I&D e Avaliaçao, Lda (MEDIDA), Porto, Portugal.
Imunoalergologia, CUF, Porto, Portugal.
ORCID: 0000-0002-0887-8796

Jean Bousquet (J)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
MACVIA-France, Montpellier, France.
University Hospital Montpellier, Montpellier, France.
ORCID: 0000-0002-4061-4766

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › Development and validation of combined...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Development and validation of combined...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Development and validation of combined...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Development and validation of combined...
questionsmedicales.fr › Maladies oto-rhino-laryngologiques › Maladies du nez › Rhinite › Development and validation of combined...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Rhinite allergique › Development and validation of combined...